gefitinib has been researched along with beta-thujaplicin in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (beta-thujaplicin) | Trials (beta-thujaplicin) | Recent Studies (post-2010) (beta-thujaplicin) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 205 | 3 | 99 |
| Protein | Taxonomy | gefitinib (IC50) | beta-thujaplicin (IC50) |
|---|---|---|---|
| E3 ubiquitin-protein ligase Mdm2 isoform a | Homo sapiens (human) | 3.58 | |
| protein Mdm4 isoform 1 | Homo sapiens (human) | 3.58 | |
| Polyphenol oxidase 2 | Agaricus bisporus | 0.09 | |
| Carboxypeptidase A1 | Bos taurus (cattle) | 2.76 | |
| Tyrosinase | Homo sapiens (human) | 8.98 | |
| Breast cancer type 1 susceptibility protein | Homo sapiens (human) | 3.89 | |
| BRCA1-associated RING domain protein 1 | Homo sapiens (human) | 3.89 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, HW; Chen, WJ; Ho, CC; Ho, CL; Hsieh, WY; Lee, JY; Li, LH; Li, PR; Wang, CC; Wu, P; Yang, SM; Yen, MY | 1 |
1 other study(ies) available for gefitinib and beta-thujaplicin
| Article | Year |
|---|---|
Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells.
Topics: Acridine Orange; Adenocarcinoma; Adenocarcinoma of Lung; Annexin A5; Antineoplastic Agents, Phytogenic; Autophagy; Blotting, Western; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cellular Senescence; Cupressaceae; DNA Damage; Drug Resistance, Neoplasm; ErbB Receptors; Gas Chromatography-Mass Spectrometry; Gefitinib; Gene Expression Profiling; Humans; Lung Neoplasms; Monoterpenes; Oils, Volatile; Quinazolines; Real-Time Polymerase Chain Reaction; Taiwan; Tropolone; Tumor Stem Cell Assay | 2014 |